linaclotide   Click here for help

GtoPdb Ligand ID: 5017

Synonyms: Constella® | Linzess® | MM-416775
Approved drug
linaclotide is an approved drug (FDA and EMA (2012))
Comment: Linaclotide represents a first-in-class, oral guanylate cyclase 2C activator [2]. It is a synthetic analogue of pathological heat-stable bacterial enterotoxins, and retains the same intrachain disulfide bond structure essential for biological activity.
Marketed formulations contain linaclotide acetate (PubChem CID 16158207). See also plecanatide, the second approved GC-C activator.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: linactolide

Classification Click here for help
Compound class Peptide or derivative
Approved drug? Yes (FDA and EMA (2012))
International Nonproprietary Names Click here for help
INN number INN
8802 linaclotide
Synonyms Click here for help
Constella® | Linzess® | MM-416775
Database Links Click here for help
CAS Registry No. 851199-59-2 (source: Scifinder)
DrugBank Ligand DB08890
GtoPdb PubChem SID 178101714
PubChem CID 16158208
Search PubMed clinical trials linaclotide
Search PubMed titles linaclotide
Search PubMed titles/abstracts linaclotide
Wikipedia Linaclotide